Gland Pharma Limited

Gland Pharma Limited

Pharmaceutical Manufacturing

Hyderabad, Telangana 79,133 followers

Ethics, Excellence and Efficacy

About us

Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.

Website
http://www.glandpharma.com
Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees
Headquarters
Hyderabad, Telangana
Type
Public Company
Founded
1978
Specialties
Sterile Injectable Products, Oncology, and Ophthalmics

Locations

  • Primary

    Sy. No: 143 to 148/150&151, DP Pally Near Gandimaisamma X Road

    Hyderabad, Telangana 500 043, IN

    Get directions
  • APIIC-I.P IIIrd Phase, Survey No: 166&171,Plot No: 42 to 52,Pashamylaram VIII,Patancheru Mandal

    Hyderabad, Telangana 502307, IN

    Get directions
  • APIIC-I.P IIIrd Phase, Survey No:172&177, Plot No:54, 55&64 to 68,Pashamylaram VIII, Patancheru Mandal

    Hyderabad, Telangana 502307, IN

    Get directions
  • Plot No: 49& 50, Jawaharlal Nehru Pharma City,Parawada

    Visakhaptnam, Andhra Pradesh 531019, IN

    Get directions
  • Block C, Phase I, VSEZ, Duvvada

    Visakhapatnam, Andhra Pradesh 530046, IN

    Get directions

Employees at Gland Pharma Limited

Updates

Affiliated pages

Similar pages

Browse jobs

Funding

Gland Pharma Limited 3 total rounds

Last Round

Private equity

US$ 200.0M

See more info on crunchbase